NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

PRPO

Precipio Inc

Jul 03 • 04:00PM ET

12.05

Dollar change +0.75
Percentage change 6.67	%

Healthcare • Diagnostics & Research • USA • NASD

Peers: HOLX BIO DGX LH NTRA NEO QGEN VERI CDNA FLGT

| Held by: VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-2.09	Insider Own	15.33%	Shs Outstand	1.50M	Perf Week	7.21%
Market Cap	18.22M	Forward P/E	-	EPS next Y	-	Insider Trans	6.96%	Shs Float	1.28M	Perf Month	13.45%
Enterprise Value	19.43M	PEG	-	EPS next Q	-	Inst Own	7.44%	Short Float	0.44%	Perf Quarter	116.73%
Income	-3.10M	P/S	0.91	EPS this Y	-	Inst Trans	50.34%	Short Ratio	0.45	Perf Half Y	118.87%
Sales	20.03M	P/B	1.55	EPS next Y	-	ROA	-17.99%	Short Interest	0.01M	Perf YTD	117.52%
Book/sh	7.78	P/C	17.86	EPS next 5Y	-	ROE	-25.29%	52W High	11.80 2.12%	Perf Year	142.45%
Cash/sh	0.67	P/FCF	26.03	EPS past 3/5Y	28.73% 42.48%	ROIC	-23.00%	52W Low	3.90 208.97%	Perf 3Y	-43.16%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	27.94% 42.74%	Gross Margin	36.54%	Volatility	6.10% 6.77%	Perf 5Y	-38.21%
Dividend TTM	-	EV/Sales	0.97	EPS Y/Y TTM	44.02%	Oper. Margin	-14.98%	ATR (14)	0.75	Perf 10Y	-99.93%
Dividend Ex-Date	-	Quick Ratio	0.57	Sales Y/Y TTM	26.67%	Profit Margin	-15.45%	RSI (14)	65.44	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.76	EPS Q/Q	59.65%	SMA20	7.96%	Beta	0.90	Target Price	19.00
Payout	-	Debt/Eq	0.19	Sales Q/Q	43.62%	SMA50	30.71%	Rel Volume	3.21	Prev Close	11.30
Employees	60	LT Debt/Eq	0.15	Earnings	May 15 AMC	SMA200	69.40%	Avg Volume	12.53K	Price	12.05
IPO	Jul 18, 2000	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	40,176	Change	6.67%

Today 04:25PM	Top Research Reports for Apple, Oracle & Goldman Sachs (Zacks) +6.67%
Jun-16-25 12:00PM	Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting (GlobeNewswire)
May-16-25 05:01PM	Precipio Inc (PRPO) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Operational ... (GuruFocus.com) +10.21% +6.22%
May-14-25 05:00PM	Precipio Announces its Q1-2025 Financial Results (GlobeNewswire)
May-01-25 05:00PM	Precipio Announces Q1-2025 Shareholder Update Call (GlobeNewswire) +15.26%
08:59AM	Loading…
Apr-22-25 08:59AM	The Zacks Analyst Blog Highlights Visa, ServiceNow, The Progressive, The Monarch Cement and Precipio (Zacks)
Apr-21-25 04:49PM	Top Research Reports for Visa, ServiceNow & Progressive (Zacks) -10.88%
Apr-02-25 09:00AM	Precipio Inc (PRPO) Q4 2024 Earnings Call Highlights: Break-Even Achieved and Strategic Growth ... (GuruFocus.com)
Mar-31-25 10:50PM	Precipio, Inc. (PRPO) Q4 2024 Earnings Call Transcript (Seeking Alpha)
Mar-17-25 05:00PM	Precipio Announces Q4 and year-end 2024 Shareholder Update Call (GlobeNewswire) +9.22% -8.06%
Feb-26-25 09:45AM	Precipio achieves positive adjusted EBITDA, cash flow in Q4 (TipRanks) -13.54%
Feb-25-25 09:30AM	Precipio Achieves Key Q4-2024 Financial Goals: Positive Adjusted EBITDA and Positive Cash Flow (unaudited) (GlobeNewswire) -12.69%
Jan-16-25 05:00PM	Precipio grants senior management performance-based awards instead of traditional time-vested ESOPs (GlobeNewswire) +5.85%
Nov-20-24 08:00AM	Precipio Inc (PRPO) Q3 2024 Earnings Call Highlights: Strong Growth in Diagnostic Services and ... (GuruFocus.com)
Nov-06-24 05:00PM	Precipio Announces Q3-2024 Shareholder Update Call (GlobeNewswire)
10:00AM	Loading…
Oct-08-24 10:00AM	Precipio Expands Bloodhound MPN Panel by Adding CALR Mutation Subtyping (GlobeNewswire)
Sep-06-24 04:00PM	Precipio Announces Employee Stock Option Plan Repricing (GlobeNewswire)
Aug-15-24 05:00PM	Precipio Announces Q2-2024 Shareholder Update Call (GlobeNewswire) +5.96%
Jul-25-24 09:00AM	Precipio Reports $0.3M cash generated by operations (unaudited) in Q2-2024, as the company advances towards breakeven (GlobeNewswire) +8.01%
Jul-17-24 09:00AM	Precipio Reports $4.4M for Q2-2024 (unaudited) Revenues, a leap of 30% from Q1-2024 (GlobeNewswire) +23.87%
Jun-13-24 04:00PM	Precipio Inc. Announces Adjournment of Annual Meeting of Stockholders (GlobeNewswire)
Jun-12-24 04:00PM	Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting (GlobeNewswire)
09:00AM	Precipio Provides Status Update on Current Business Matters (GlobeNewswire)
May-15-24 08:52AM	PRPO Stock Earnings: Precipio Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
May-06-24 05:00PM	Precipio Secures a short-term $500K Credit Facility (GlobeNewswire)
Apr-01-24 10:53AM	PRPO Stock Earnings: Precipio Beats EPS, Misses Revenue for Q4 2023 (InvestorPlace)
Mar-25-24 05:00PM	Precipio Announces Year end 2023 Shareholder Update Call (GlobeNewswire)
Feb-13-24 10:00AM	Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoY (GlobeNewswire)
Feb-06-24 10:00AM	Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen Portfolio of Molecular assays for Cancer (GlobeNewswire) +8.24%
Jan-23-24 10:00AM	Precipio's Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarter (GlobeNewswire)
10:30AM	Loading…
Jan-17-24 10:30AM	Precipio Signs Distribution Agreement For IV-Cell and HemeScreen in Japan (GlobeNewswire) +15.37%
Jan-02-24 09:00AM	Precipio Announces Christina Valauri joins the Board of Directors (GlobeNewswire)
Dec-14-23 04:30PM	Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024 (GlobeNewswire) +12.40%
Nov-16-23 05:00PM	Precipio Announces Q3-2023 Shareholder Update Call (GlobeNewswire) -7.74%
Oct-18-23 09:00AM	Precipio to Report $4.5M Q3-2023 Revenues, Double From Q3-2022 (GlobeNewswire)
Oct-03-23 10:00AM	Precipio's Q3 Cash Burn From Operations (unaudited) Declines 59% YoY, from $2.5M in Q3-2022 to approximately $1M in Q3-2023 (GlobeNewswire)
Sep-28-23 09:00AM	Precipio Continues to Sign New HemeScreen Customers (GlobeNewswire)
Sep-25-23 11:00AM	Precipio Reduces Product Revenue Result Needed for Cash Flow Breakeven (GlobeNewswire)
Sep-21-23 09:00AM	Precipio Takes Final Step Towards Regaining Nasdaq Compliance (GlobeNewswire) -10.41%
Sep-13-23 09:30AM	Precipios Pathology Division Exceeds Breakeven Revenues in August, Four Months Ahead of Plan (GlobeNewswire) +7.80%
Aug-31-23 03:26PM	11 ChatGPT Penny Stock Picks (Insider Monkey)
Aug-19-23 06:01AM	Precipio, Inc. (NASDAQ:PRPO) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-13-23 10:16AM	Precipio, Inc.'s (NASDAQ:PRPO) Shares Not Telling The Full Story (Simply Wall St.)
Aug-10-23 05:00PM	Precipio Announces Q2-2023 Shareholder Update Call (GlobeNewswire)
Aug-08-23 09:00AM	Precipio Launches Its Much-Anticipated Quantitative BCR-ABL 2.0 Panel (GlobeNewswire)
Aug-03-23 09:00AM	Precipios Operational Efficiency Measures Continue To Reduce Cash Burn And Move The Company Towards Breakeven (GlobeNewswire)
Aug-01-23 09:00AM	Precipio Unaudited Q2-2023 Revenues Show combined increase of 25% over Q1-2023 (GlobeNewswire) +5.74%
Jun-14-23 09:49AM	Precipios Omnia Methodology Enables Diagnosis of MDS With Peripheral Blood Instead of Bone Marrow Biopsy (GlobeNewswire)
Jun-13-23 09:00AM	Precipio Enters into Collaboration with Prestigious New York-based Institution to Develop Revolutionary Brain Tumor Panel using HemeScreen® Technology (GlobeNewswire)
Jun-08-23 08:30AM	Precipio, Inc. Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement (GlobeNewswire) -29.40%
Jun-07-23 09:30AM	Projected cash burn reduced by $1.5 million annually from Three Operational Efficiency Projects (GlobeNewswire) +15.23%
May-22-23 11:00AM	Precipios Lab Detects BCR-ABL1 Oncogene Co-Expression of p190 & p210 Isoforms in a CML Patient By Using HemeScreen® Technology (GlobeNewswire)
May-17-23 04:00PM	Precipio Shares Growth Catalysts For HemeScreen (GlobeNewswire)
May-15-23 04:00PM	Precipio Announces Q1-2023 Shareholder Update Call (GlobeNewswire)
May-04-23 01:00PM	Precipio Adds Substantial Pathology Customer to its Diagnostic Services Division (GlobeNewswire) -6.71%
10:00AM	Precipio Signs Another HemeScreen Customer (GlobeNewswire)
Apr-27-23 05:00PM	Precipio Granted 180-day Extension From NASDAQ To Regain Compliance (GlobeNewswire)
Apr-19-23 11:00AM	Precipio Unaudited Q1-2023 Product Revenues Exceed The Two Prior Quarters (Q3+Q4 of 2022) Combined (GlobeNewswire)
Apr-09-23 10:25AM	Precipio, Inc. (NASDAQ:PRPO) Q4 2022 Earnings Call Transcript (Insider Monkey)
Apr-02-23 08:55AM	Precipio Full Year 2022 Earnings: US$0.54 loss per share (vs US$0.40 loss in FY 2021) (Simply Wall St.)
Mar-28-23 05:00PM	Precipio Announces 2022 Fourth Quarter and Year-End Shareholder Update Call (GlobeNewswire)
Mar-21-23 10:30AM	Precipio Ships First IV-Cell® Order to Major US Healthcare System (GlobeNewswire)
Mar-07-23 12:49PM	CORRECTION -- Precipio continues to sign up and onboard HemeScreen customers (GlobeNewswire)
12:00PM	Precipio continues to sign up and onboard HemeScreen customers (GlobeNewswire)
Feb-14-23 11:44AM	ThermoFisher Salesforce Votes Precipios HemeScreen® as Best New Product (GlobeNewswire)
Jan-11-23 10:00AM	Precipio Signs Another Major HemeScreen Customer (GlobeNewswire) +7.21%
Dec-06-22 10:00AM	Precipio Signs Additional Major HemeScreen Customer (GlobeNewswire)
Nov-07-22 10:30AM	Precipio Presents Poster on HemeScreen® Study at Association of Molecular Pathology (AMP) 2022 Annual Conference (GlobeNewswire)
Nov-02-22 05:00PM	Precipio Announces Third Quarter Shareholder Update Call (GlobeNewswire)
Oct-18-22 09:07AM	Precipio, Inc. (NASDAQ:PRPO) Is Expected To Breakeven In The Near Future (Simply Wall St.)
Sep-15-22 11:00AM	Precipio Signs Agreement with Another Major US Healthcare Distributor for HemeScreen (GlobeNewswire) +8.33%
Aug-24-22 11:00AM	Sharon Robins Joins Precipios Products Division as Senior Director of Laboratory & Hospital Sales (GlobeNewswire)
Aug-16-22 11:00AM	Precipio Launches New 1-Step Technology for all HemeScreen Assays (GlobeNewswire) -10.67%
Aug-10-22 10:00AM	Toni-Ann Mills Joins Precipios Products Division to Lead Channel Partner Training, Learning & Development (GlobeNewswire)
Aug-08-22 10:00AM	Precipio Announces Second Quarter Shareholder Update Call (GlobeNewswire)
Jul-20-22 10:30AM	Precipio to distribute HemeScreen® through Fisher Healthcare channel (GlobeNewswire)
Jun-14-22 02:00PM	Precipio requests that all Stockholders that have not yet voted, proceed to cast their vote (GlobeNewswire)
Jun-13-22 11:00AM	Keith Meadors Joins Precipio to Lead its Products Division (GlobeNewswire) -9.40%
May-24-22 10:30AM	Precipio Receives CE-IVD Certification to Market Multiple HemeScreen® Panels in Europe (GlobeNewswire)
May-11-22 08:15AM	When Will Precipio, Inc. (NASDAQ:PRPO) Breakeven? (Simply Wall St.) -11.40%
May-10-22 10:30AM	Precipio Signs First IV-Cell Customer Agreement (GlobeNewswire) +15.91%
Apr-26-22 10:00AM	Precipio customer American Oncology Network (AON) selected to present HemeScreen® technology case study at Industry leading clinical laboratory conference (GlobeNewswire)
Mar-22-22 06:00PM	Precipio Announces 2021 Fourth Quarter and Year-End Shareholder Update Call (GlobeNewswire)
Mar-21-22 05:00PM	Precipio Inc. Announces the Resignation of its Chief Financial Officer and Appointment of Interim CFO (GlobeNewswire)
Feb-24-22 10:00AM	Precipio Releases Year-End 2021 Preliminary Unaudited Results and Outlook for 2022 (GlobeNewswire)
Nov-29-21 07:27AM	Todays Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace) +7.33%
Nov-18-21 10:00AM	New York State Approves Precipios HemeScreen for POL clinical use (GlobeNewswire)
Nov-03-21 08:00AM	89bio Announces Appointment of Kathy LaPorte to its Board of Directors (GlobeNewswire)
Nov-01-21 05:00PM	Precipio Announces Q3-2021 and year-end Shareholder Update Call (GlobeNewswire) +10.38%
03:54PM	Precipio (NASDAQ:PRPO) shareholders have endured a 44% loss from investing in the stock three years ago (Simply Wall St.)
Aug-26-21 10:00AM	American Oncology Network Partners with Precipio to Bring HemeScreen® into AONs Laboratory (GlobeNewswire) +5.52%
Aug-20-21 05:00PM	Precipio Reschedules Q2-2021 Shareholder Update Call (GlobeNewswire)
Aug-13-21 10:48AM	Precipio Corrects Announcement of Q2-2021 Shareholder Update Call (GlobeNewswire)
Aug-12-21 05:00PM	Precipio Announces Q2-2021 and year-end Shareholder Update Call (GlobeNewswire)
Jul-28-21 10:00AM	Precipio Announces Preliminary Unaudited Q2-2021 Revenues of $2.3M (GlobeNewswire)
Jun-15-21 11:00AM	Precipio Terminates its Equity Line (GlobeNewswire) -5.51%
Jun-08-21 10:30AM	Precipio Launches HemeScreen® Anemia Panel, a One-of-its-Kind Testing Tool (GlobeNewswire) +18.47%
May-20-21 03:15PM	Precipio, Inc. to Host Earnings Call (ACCESSWIRE) +14.77%
May-14-21 04:30PM	Precipio Announces Q1-2021 and year-end Shareholder Update Call (GlobeNewswire) +15.27%
May-10-21 10:30AM	Precipio Launches New HemeScreen Panel for AML, with an unparalleled 4-hour turnaround-time (GlobeNewswire) +15.62%

Precipio, Inc.is a cancer diagnostics and reagent technology company, which provides diagnostic products and services to the oncology market. Its products include ICP, HemeScreen, and IV-Cell, and services include primary diagnostic, SmartPath, SmartGen, HemeScreen Panel, and ICE COLD-PCR. The company was founded on March 6, 1997 and is headquartered in New Haven, CT.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
SANDBERG RICHARD A	Director	May 30 '25	Buy	10.00	1,399	13,986	40,175	May 30 04:31 PM
SANDBERG RICHARD A	Director	May 27 '25	Buy	9.80	101	990	38,776	May 28 04:37 PM
SANDBERG RICHARD A	Director	May 22 '25	Buy	9.33	500	4,665	38,675	May 27 04:05 PM
SANDBERG RICHARD A	Director	May 21 '25	Buy	9.27	8,035	74,474	38,175	May 22 05:01 PM
SANDBERG RICHARD A	Director	May 20 '25	Buy	8.47	4,251	36,006	30,140	May 21 04:34 PM
SANDBERG RICHARD A	Director	May 19 '25	Buy	8.21	714	5,862	25,889	May 21 04:34 PM
Sabet Ahmed Zaki	Chief Operating Officer	Apr 02 '25	Buy	6.00	79	474	939	Apr 04 05:00 PM
SANDBERG RICHARD A	Director	Dec 13 '24	Buy	5.80	15,000	87,000	19,525	Dec 13 04:35 PM
SANDBERG RICHARD A	Director	Dec 13 '24	Sale	6.20	12,000	74,400	4,525	Dec 13 04:35 PM
SANDBERG RICHARD A	Director	Dec 11 '24	Proposed Sale	5.90	14,034	82,800		Dec 11 10:22 AM
SANDBERG RICHARD A	Director	Nov 11 '24	Sale	6.28	2,000	12,558	16,525	Nov 12 07:18 PM
SANDBERG RICHARD A	Director	Nov 11 '24	Proposed Sale	6.03	2,000	12,055		Nov 12 09:03 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PRPO

Precipio Inc

Upgrade your FINVIZ experience